Toronto Dominion Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.71M | Buy |
23,631
+4,246
| +22% | +$1.38M | 0.01% | 533 |
|
|
2025
Q1 | $5.23M | Buy |
19,385
+2,611
| +16% | +$705K | 0.01% | 552 |
|
|
2024
Q4 | $3.95M | Buy |
16,774
+1,308
| +8% | +$308K | 0.01% | 620 |
|
|
2024
Q3 | $4.25M | Buy |
15,466
+3,315
| +27% | +$912K | 0.01% | 553 |
|
|
2024
Q2 | $2.95M | Sell |
12,151
-835
| -6% | -$203K | ﹤0.01% | 628 |
|
|
2024
Q1 | $1.94M | Sell |
12,986
-36,161
| -74% | -$5.4M | ﹤0.01% | 689 |
|
|
2023
Q4 | $9.41M | Sell |
49,147
-6,115
| -11% | -$1.17M | 0.01% | 479 |
|
|
2023
Q3 | $9.79M | Buy |
55,262
+24,400
| +79% | +$4.32M | 0.02% | 435 |
|
|
2023
Q2 | $5.86M | Sell |
30,862
-3,317
| -10% | -$630K | 0.01% | 583 |
|
|
2023
Q1 | $6.84M | Sell |
34,179
-2,491
| -7% | -$499K | 0.01% | 519 |
|
|
2022
Q4 | $8.71M | Buy |
36,670
+9,911
| +37% | +$2.35M | 0.01% | 452 |
|
|
2022
Q3 | $5.35M | Sell |
26,759
-61
| -0.2% | -$12.2K | 0.01% | 534 |
|
|
2022
Q2 | $3.91M | Buy |
26,820
+1,207
| +5% | +$176K | 0.01% | 610 |
|
|
2022
Q1 | $4.18M | Buy |
25,613
+2,185
| +9% | +$357K | 0.01% | 625 |
|
|
2021
Q4 | $3.97M | Buy |
23,428
+8,089
| +53% | +$1.37M | 0.01% | 668 |
|
|
2021
Q3 | $2.9M | Sell |
15,339
-451
| -3% | -$85.1K | ﹤0.01% | 685 |
|
|
2021
Q2 | $2.68M | Buy |
15,790
+97
| +0.6% | +$16.4K | ﹤0.01% | 686 |
|
|
2021
Q1 | $2.22M | Sell |
15,693
-6,136
| -28% | -$866K | ﹤0.01% | 709 |
|
|
2020
Q4 | $2.84M | Buy |
21,829
+2,620
| +14% | +$341K | 0.01% | 685 |
|
|
2020
Q3 | $2.8M | Buy |
19,209
+2,074
| +12% | +$302K | 0.01% | 639 |
|
|
2020
Q2 | $2.54M | Buy |
17,135
+2,095
| +14% | +$310K | 0.01% | 677 |
|
|
2020
Q1 | $1.64M | Sell |
15,040
-4,428
| -23% | -$482K | 0.01% | 650 |
|
|
2019
Q4 | $2.24M | Buy |
19,468
+1,679
| +9% | +$193K | ﹤0.01% | 635 |
|
|
2019
Q3 | $1.43M | Sell |
17,789
-11,395
| -39% | -$916K | ﹤0.01% | 693 |
|
|
2019
Q2 | $1.06M | Buy |
29,184
+12,811
| +78% | +$465K | ﹤0.01% | 732 |
|
|
2019
Q1 | $1.53M | Buy |
16,373
+4,163
| +34% | +$389K | ﹤0.01% | 673 |
|
|
2018
Q4 | $890K | Buy |
12,210
+2,383
| +24% | +$174K | ﹤0.01% | 705 |
|
|
2018
Q3 | $860K | Buy |
9,827
+869
| +10% | +$76.1K | ﹤0.01% | 703 |
|
|
2018
Q2 | $882K | Buy |
8,958
+2,900
| +48% | +$286K | ﹤0.01% | 698 |
|
|
2018
Q1 | $721K | Buy |
6,058
+842
| +16% | +$100K | ﹤0.01% | 671 |
|
|
2017
Q4 | $663K | Buy |
+5,216
| New | +$663K | ﹤0.01% | 661 |
|
|
2016
Q4 | – | Sell |
-664
| Closed | -$45K | – | 1027 |
|
|
2016
Q3 | $45K | Buy |
664
+243
| +58% | +$16.5K | ﹤0.01% | 860 |
|
|
2016
Q2 | $23K | Buy |
421
+3
| +0.7% | +$164 | ﹤0.01% | 875 |
|
|
2016
Q1 | $26K | Buy |
+418
| New | +$26K | ﹤0.01% | 852 |
|